Drugs / HCP1202
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT02941679 | Oct 2016 → Feb 2018 | chronic obstructive pulmonary disease | Hanmi Pharmaceutical Company Limited | Unknown | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | HCP1202 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02941679 ↗ |